The Patient Partnership Index 2020 is a ground-breaking initiative from leading industry publication PharmaTimes magazine and specialist health communications agency OVID Health.

Launched in May 2020, the Index offers pharmaceutical and biotech companies an opportunity to showcase, benchmark and evaluate the quality of their communications and advocacy with patient groups. The aim is to celebrate as many companies that meet the mark, so we can raise the bar across the industry. There are no costs involved – entering the Index is completely free for everyone.

The Index will evaluate the highest standards, based on best practice, of partnerships in communications and advocacy between pharmaceutical, biotech and patient communities.

Companies are offered the opportunity to submit entries to the Index. In return, they will be recognised amongst their industry peers and patient organisations, as well as receive an exclusive insights report from OVID Health. The deadline for entries is June 23rd 2020.

“Having a Patient Partnership Index, developed with patient groups and judged independently, can keep us moving forwards, sharing best practice and providing a valuable steer on what works best”

Ben Osborn, Pfizer UK country manager

The final results will be announced in the September issue of PharmaTimes and all entrants will have the opportunity to profile their involvement with the Index through their own external and internal channels.

“We work hard to build trusted, transparent and lasting relationships with patient organisations, no matter how big or small, to help us understand what matters most to patients and their families……we value platforms such as the Patient Partnership Index which enable us to share our initiatives and learn of other important programmes helping to meet the needs of UK patients.”

Gaetan leblay, managing Director of janssen UK & Ireland
Entries are now open for the Patient Partnership Index 2020